The Division of Pharmacy at The University of Texas MD Anderson Cancer Center offers an ASHP accredited one-year PGY2 Oncology Pharmacy residency program.  MD Anderson is a world-renowned comprehensive cancer center.  The institution has more than 700 inpatient beds and over 4000 outpatient clinic visits daily. Our structured PGY2 Oncology program is concentrated in direct patient care activities designed to develop clinical expertise and competence in the pharmacotherapeutic management of cancer patients.  Core residency learning experiences provide exposure to a variety of solid tumor, malignant hematology, and stem cell transplant patient populations as well as elective time that will be tailored to the interests and career goals of the resident.  Residents will also gain experience